Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Maine Medical Center
mi
from
Scarborough, ME
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Maine Medical Center
mi
from
Scarborough, ME
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Maryland School of Medicine
mi
from
Baltimore, MD
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Massachusetts General Hospital
mi
from
Boston, MA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Umass Memorial Medical Center
mi
from
Worcester, MA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Umass Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Cleveland Clinic
mi
from
Cleveland, OH
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Oregon Health & Science University Hospital
mi
from
Portland, OR
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Oregon Health & Science University Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Abington Memorial Hospital
mi
from
Abington, PA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Medical University of South Carolina
mi
from
Charleston, SC
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Utah Healthcare
mi
from
Salt Lake City, UT
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Utah Healthcare
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Stanford Hospital and Clinics
mi
from
Stanford, CA
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Washington University and Barnes Jewish Heart & Vascular Center
mi
from
Saint Louis, MO
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Washington University and Barnes Jewish Heart & Vascular Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Childrens Hospital & Medical Center
mi
from
Omaha, NE
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Childrens Hospital & Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated:  6/6/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Patient-Reported Outcomes in Adults With Congenital Heart Disease
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
Status: Enrolling
Updated: 6/6/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Southeast Retina
mi
from
Augusta, GA
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Southeast Retina
mi
from
Augusta, GA
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Retina Associates of Kentucky
mi
from
Lexington, KY
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Boston V.A. Healthcare System
mi
from
West Roxbury, MA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Boston V.A. Healthcare System
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Christiana Care Health Services, Inc
mi
from
Newark, DE
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Durham VA Medical Center
mi
from
Durham, NC
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Emory University School of Medicine
mi
from
Atlanta, GA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Jefferson Medical College
mi
from
Philadelphia, PA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Jefferson Medical College
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Lancaster General Hospital
mi
from
Lancaster, PA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Massachusetts General Hospital
mi
from
Boston, MA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Metro Health System
mi
from
Cleveland, OH
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Northwestern University
mi
from
Chicago, IL
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Temple University Hospital
mi
from
Philadelphia, PA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Tufts Medical Center
mi
from
Boston, MA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
University of Utah Hospitals and Clinics
mi
from
Salt Lake City, UT
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
University of Utah Hospitals and Clinics
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
V.A. Medical Center
mi
from
Salt Lake CIty, UT
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
V.A. Medical Center
mi
from
Salt Lake CIty, UT
Click here to add this to my saved trials
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  6/17/2014
Washington University School of Medicine
mi
from
St Louis, MO
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 6/17/2014
Washington University School of Medicine
mi
from
St Louis, MO
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Dr. Haines
mi
from
Kaplan, Phoenix, AZ
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Dr. Haines
mi
from
Kaplan, Phoenix, AZ
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Drs. Lewis, Garg
mi
from
Siegel, Phoenix, AZ
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Drs. Lewis, Garg
mi
from
Siegel, Phoenix, AZ
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Drs. Jagmeet Singh, Kevin, Hiest
mi
from
Boston, MA
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Drs. Jagmeet Singh, Kevin, Hiest
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Drs. John Fisher, Jay Gross
mi
from
Montefiore, Bronx NY, NY
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Drs. John Fisher, Jay Gross
mi
from
Montefiore, Bronx NY, NY
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Dr. Gold
mi
from
Charleston, SC
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Dr. Gold
mi
from
Charleston, SC
Click here to add this to my saved trials
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated:  6/17/2014
Dr. Champagne, Dr. Philippon
mi
from
Quebec,
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT
Status: Enrolling
Updated: 6/17/2014
Dr. Champagne, Dr. Philippon
mi
from
Quebec,
Click here to add this to my saved trials
Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
Status: Enrolling
Updated:  6/25/2014
University of Chicago
mi
from
Chicago, IL
Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
Status: Enrolling
Updated: 6/25/2014
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials